Erasca, Inc. (ERAS) at a glance

Erasca, Inc. (ERAS) is a mid-cap Healthcare company. It trades at $16.52, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Momentum (62/100) and its weakest is Value (40/100). Its volatility is roughly in line with the market.

Price
$16.52
Market cap
$4.37B
P/E ratio
n/a
Dividend yield
None
Beta
0.73
52-week range
$1.33 to $24.28
Vestovix Score49/ 100How this works
Value
40
Growth
50
Income
40
Safety
60
Momentum
62

Other Healthcare stocks

See all